2 results
Approved WMORecruiting
The primary objective of the SPIRIT*HF study is to compare Spironolactone to Placebo in reducing the rate…
Approved WMOCompleted
Primary Objective:• To evaluate event-free survival (EFS) after blinatumomab when compared to standard ofcare (SOC) chemotherapySecondary Objective(s):• To evaluate the effect of blinatumomab on overall survival (OS) when compared to SOCchemotherapy…